Home › Funds › Sofinnova Investments, Inc. › JAZZ
Sofinnova Investments, Inc. position in JAZZ
JAZZ PHARMACEUTICALS PLC SHS USD · Health Care
Sofinnova Investments, Inc. reported holding 365,341 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$88.0M, representing 4.69% of its reported portfolio and ranking #4 among its reported holdings. Sofinnova Investments, Inc. has disclosed JAZZ holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s JAZZ position evolved
Sofinnova Investments, Inc. first disclosed a stake in JAZZ in Q3 2024 at 188,562 shares (US$21.0M). The position peaked in Q4 2025 at 959,860 shares, worth US$163.2M. Across 8 filings, Sofinnova Investments, Inc. increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 365,341 shares valued at US$88.0M — a reduction of -232,986 shares quarter over quarter.. Notable position changes include a 167% increase in Q4 2024 (shares were roughly flat over the following quarter), a 63% increase in Q4 2025 (shares rose 11% over the following quarter), a 39% trim in Q2 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 188.56K | $21.01M | New |
| Q4 2024 | 504.19K | $62.09M | Add |
| Q1 2025 | 510.05K | $63.32M | Add |
| Q2 2025 | 694.10K | $73.66M | Add |
| Q3 2025 | 588.83K | $77.61M | Reduce |
| Q4 2025 | 959.86K | $163.18M | Add |
| Q1 2026 | 598.33K | $113.11M | Reduce |
| Q2 2026 | 365.34K | $88.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 43 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 443.12K sh · $106.78M · Q2 2026
- SYSTEMATIC FINANCIAL MANAGEMENT LP 378.71K sh · $91.26M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held JAZZ?
Sofinnova Investments, Inc. has disclosed JAZZ holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is Sofinnova Investments, Inc.'s current position in JAZZ?
As of Q2 2026, Sofinnova Investments, Inc. holds 365.34K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $88.04M, representing 4.69% of its reported portfolio and ranking #4.
Has Sofinnova Investments, Inc. been buying or selling JAZZ?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. reduced its position in JAZZ. The position peaked in Q4 2025 at 959.86K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.